Gene: COL14A1
Official Full Name: collagen type XIV alpha 1 chainprovided by HGNC
Gene Summary: This gene encodes the alpha chain of type XIV collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XIV collagen interacts with the fibril surface and is involved in the regulation of fibrillogenesis. [provided by RefSeq, Jan 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34847 | COL14A1 Knockout cell line (HeLa) | Human | COL14A1 | 1:3~1:6 | Negative | Online Inquiry |
COL14A1 Gene Knockout Cell Lines are precisely engineered cellular models that have had the COL14A1 gene, known for its role in collagen assembly, absent from their genome. These knockout cell lines serve as essential tools for understanding the functional implications of COL14A1 deficiency in various biological contexts. By removing the COL14A1 gene, researchers can investigate how this alteration influences cellular behaviors, signaling pathways, and the overall extracellular matrix composition, which can have profound implications for fibrosis, cancer, and other connective tissue disorders.
The mechanism of action for these knockout cell lines lies in the strategic disruption of the COL14A1 gene, achieved through advanced CRISPR-Cas9 technology, ensuring specific and reproducible gene ablation. The resulting cells can be utilized for a multitude of experimental applications, including drug screening, gene function analysis, and the study of disease models. By providing a model that simulates the pathophysiological processes associated with COL14A1 deficiency, these cell lines open avenues for targeted therapeutic development and innovative research.
In clinical and research settings, the COL14A1 Knockout Cell Lines stand out due to their precise genetic modifications and the ability to facilitate studies of gene function in a controlled environment. They offer advantages over traditional models such as primary cells or animal models by allowing for high-throughput screening and reducing variabilities associated with biological systems. Furthermore, the availability of these cell lines allows for streamlined research processes, ultimately accelerating the understanding of disease mechanisms.
For researchers and clinicians focused on connective tissue disorders or cancer biology, the COL14A1 Gene Knockout Cell Lines are invaluable. They provide a reliable platform for experimental manipulation and a deeper insight into the molecular underpinnings of health and disease. At [Company Name], we pride ourselves on our expertise in developing cutting-edge cellular models, ensuring that our products enable researchers to push the boundaries of scientific knowledge while supporting advancements in therapeutic interventions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.